ClinicalTrials.gg
Enrolling by invitationNCT07928817Thai-FITsUpdated Nov 10, 2026

Effects of Thai Food-Specific Inhibition Control Training on Psychophysiological Outcomes in Thai Adults With Obesity

An interventional study of Thai Food-Specific Inhibition Control Training and General Inhibition Control Training in Obesity & Overweight and Obesity (Disorder), sponsored by Burapha University. Enrolling by invitation at 1 site in Thailand. Open to participants aged 18 Years to 59 Years. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Burapha University · Not applicable, Interventional, and Treatment

Updated Nov 10, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
18 Years to 59 Years
Sex
All
01

Study summary

This randomized controlled trial aims to investigate the effects of Thai food-specific inhibition control training on psychological, physiological, behavioral, and neurophysiological outcomes in Thai adults with obesity.

A total of 72 participants will be randomly assigned to either a Thai food-specific inhibition control training group (n = 36) or a general inhibition control training group (n = 36). Both groups will receive training five days per week for eight consecutive weeks.

Psychological, anthropometric, and eating-related behavioral outcomes will be assessed at baseline (T0), immediately after the eight-week intervention (T1), and at a four-week post-intervention follow-up (T2). Event-related potential components, including N2 and P3, will be assessed at baseline and immediately after the intervention.

The study will compare changes in outcomes between the two intervention groups over time to determine whether Thai food-specific inhibition control training produces different effects from general inhibition control training.

Read the detailed description

Background

Obesity is a multifactorial condition involving physiological, psychological, cognitive, environmental, and behavioral factors. Inhibitory control, a component of executive functioning, is involved in regulating behavioral responses to food-related stimuli. Training inhibitory control in response to culturally relevant food stimuli may provide a behavioral approach to improving eating-related self-regulation.

Study Objectives

The study aims to compare the effects of Thai food-specific inhibition control training with general inhibition control training on psychological outcomes, including health-related quality of life, psychological distress, psychological well-being, and self-esteem, as well as physiological and behavioral outcomes, including anthropometric measurements, eating behavior, eating inhibition control behavior, and neurophysiological indicators of cognitive control.

Study Design

This is a two-arm, parallel-group randomized controlled trial involving 72 Thai adults with obesity. Participants will be allocated to one of two intervention groups, with 36 participants planned per group.

Interventions

The experimental group will receive Thai food-specific inhibition control training. The active comparator group will receive general inhibition control training. Both interventions will be conducted five days per week over eight consecutive weeks.

Assessments

The study includes three assessment periods: baseline (T0), post-intervention at eight weeks (T1), and follow-up four weeks after the intervention (T2).

Psychological outcomes will be measured using the Short Form-36 Health Survey (SF-36), Mental Health Inventory (MHI-38), and Rosenberg Self-Esteem Scale (RSE-10).

Eating-related outcomes will be assessed using the Dutch Eating Behavior Questionnaire (DEBQ), Power of Food Scale (PFS), and Eating Inhibition Control Behavior Questionnaire (EICB).

Anthropometric assessments will include body weight, body mass index, and waist circumference.

Neurophysiological assessments will use electroencephalography to examine event-related potential components associated with inhibitory control, particularly N2 and P3, at baseline and after the eight-week intervention.

Statistical Analysis

Descriptive statistics will be used to summarize participant characteristics. Mixed repeated-measures analysis of variance will be used to evaluate the effects of group, time, and group-by-time interactions on study outcomes, with the statistical significance level set at 0.05.

The principal scientific comparison concerns differences in changes between the two training groups over time.

02

Conditions studied

  • Obesity & Overweight
  • Obesity (Disorder)

Keywords

  • Response Inhibition
  • Inhibitory Control
  • Thai Food
  • Cognitive Training
  • Go/No-Go Task
  • Event-Related Potentials
  • Eating Behavior
03

In context

Obesity

11,522 studies on the registry are indexed under Obesity; 2,033 are open to participants now.

This study's planned enrollment of 72 is close to the median of 67 across 9,006 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Burapha University is the lead sponsor of 15 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 59 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Thai adults aged 18-59 years.
  • (BMI) ≥25 kg/m² and abdominal obesity defined by waist circumference ≥90 cm for men or ≥80 cm for women.
  • Normal or corrected-to-normal vision.
  • Sufficient Thai-language proficiency to understand the study instructions.
  • No history of diagnosed or treated eating disorders, psychiatric disorders, or neurological disorders, as assessed according to the study screening procedures.
  • No history of medications affecting appetite, satiety, gastrointestinal hormones, or dopaminergic functioning, as defined in the study protocol.
  • No metabolic or chronic diseases associated with obesity, including diabetes mellitus or cardiovascular disease, as defined in the study protocol.
  • No participation in an energy-restricted dietary program within three months before the intervention.
  • No smoking or recreational drug use.
  • Not pregnant or breastfeeding during the study.
  • Ability to complete the study questionnaires and assessments.

Exclusion criteria

Exclusion Criteria:

  • Development of a physical or psychological condition during the study that may increase participation-related risks or compromise participant safety.
  • Diagnosis of or initiation of treatment for an eating disorder during the study.
  • Major life events or circumstances that prevent continued participation in scheduled research activities.
  • Adverse events that, in the investigator's judgment, require discontinuation of study participation for safety reasons.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
72 participants (estimated)

Study arms

  • Experimental
    Thai Food-Specific Inhibition Control Training

    Participants assigned to the experimental group will receive a Thai food-specific response inhibition training program incorporating food-related inhibitory control tasks. The training is designed to strengthen inhibitory control in response to Thai food stimuli. Participants will receive the intervention five days per week for eight consecutive weeks.

    Behavioral: Thai Food-Specific Inhibition Control Training

  • Active comparator
    General Inhibition Control Training

    Participants assigned to the active comparator group will receive a general response inhibition training program that is not specifically focused on Thai food stimuli. Participants will receive the intervention five days per week for eight consecutive weeks.

    Behavioral: General Inhibition Control Training

Interventions

  • BehavioralThai Food-Specific Inhibition Control Training

    Thai Food-Specific Inhibition Control Training

  • BehavioralGeneral Inhibition Control Training

    General Inhibition Control Training

06

What researchers measure

Primary outcomes

  1. Change in Body Weight

    Body weight measured in kilograms using a weighing scale

    Time frame: Baseline, Week 8, and Week 12.

  2. Change in Body Mass Index

    BMI calculated as body weight in kilograms divided by height in meters squared.

    Time frame: Baseline, Week 8, and Week 12.

  3. Change in Waist Circumference

    Waist circumference measured in centimeters using a measuring tape.

    Time frame: Baseline, Week 8, and Week 12.

Secondary outcomes

  1. Change in Eating Behavior

    Measured using the Dutch Eating Behavior Questionnaire (DEBQ)

    Time frame: Baseline, Week 8, and Week 12. Specify total or subscale scores and scoring range.

  2. Change in Power of Food Scale Score

    Measured using the Power of Food Scale (PFS)

    Time frame: Baseline, Week 8, and Week 12. Specify scoring range and interpretation

  3. Change in Eating Inhibition Control Behavior Score

    Measured using the 54-item Eating Inhibition Control Behavior Questionnaire (EICB). Total score ranges from 54 to 270; higher scores indicate better eating inhibition control behavior

    Time frame: Baseline, Week 8, and Week 12

  4. Change in Health-Related Quality of Life

    Measured using the SF-36 Health Survey

    Time frame: Baseline, Week 8, and Week 12. Specify the eight domain scores or prespecified summary scores.

  5. Change in Mental Health

    Measured using the Mental Health Inventory-38 (MHI-38)

    Time frame: Baseline, Week 8, and Week 12. Specify psychological distress and well-being scoring.

  6. Change in Self-Esteem

    Measured using the 10-item Rosenberg Self-Esteem Scale (RSE-10)

    Time frame: Baseline, Week 8, and Week 12. Confirm scoring convention.

  7. Change in N2 Event-Related Potential Amplitude

    N2 amplitude measured in microvolts (µV) during the inhibitory control task

    Time frame: Baseline and Week 8. Confirm electrode, task condition, and latency window

  8. Change in P3 Event-Related Potential Amplitude

    P3 amplitude measured in microvolts (µV) during the inhibitory control task

    Time frame: Baseline and Week 8. Confirm electrode, task condition, and latency window

07

Study locations

1 site
  • The College of Research Methodology and Cognitive Science (RMCS)
    Chon Buri, Changwat Chon Buri 20131, Thailand
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Dec 2026, 2 months later.

Of 3,680 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 2 months is below that.

Counting every sponsor, half of 3,843 studies reached it within 22 months; a quarter within 10 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 4, 2026
First posted
Nov 10, 2026
StartEst.
Oct 26, 2026
Primary completionEst.
Dec 28, 2026
CompletionEst.
Feb 28, 2027
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07928817
Lead sponsor
Burapha University
Responsible party
Chaiwat Daorueng (PhD Candidate, Burapha University) — Principal investigator
First posted
Nov 10, 2026
Start date
Oct 26, 2026 (estimated)
Primary completion
Dec 28, 2026 (estimated)
Completion
Feb 28, 2027 (estimated)
Last update
Nov 10, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion